Cancer Research Center of Hawai'i, Honolulu, HI 96813, USA.
Free Radic Biol Med. 2010 Jun 15;48(12):1610-7. doi: 10.1016/j.freeradbiomed.2010.03.002. Epub 2010 Mar 11.
Coenzyme Q10 (Q10) is present in the circulation mainly in its reduced form (ubiquinol-10; UL10), but oxidizes quickly ex vivo to ubiquinone-10 (UN10). Therefore, native UL10:UN10 ratios, used as markers of redox status and disease risk, are difficult to measure. We established an RP-(U)HPLC method with coulometric detection to measure natively circulating UL10 and UN10 concentrations by adding a ubiquinol/ubiquinone mixture as an internal standard immediately after plasma preparation. This allowed adjustment for unavoidable artificial UL10 oxidation as well as for total losses (or gains) of analytes during sample storage, processing, and analysis because the internal standards exactly paralleled the chemical behavior of Q10. This technique applied to blood (n = 13) revealed Q10 levels of 680-3300 nM with a mean UL10:UN10 ratio of 95:5, which was inversely associated with total Q10 (r=-0.69; p=0.004). The oxidation of UL10 to UN10 was equimolar, increased by O(2), and decreased by lower temperatures or various degassing methods. Although UL10 was stable in blood or when pure in organic solvents at 22 degrees C, its oxidation was catalyzed dose dependently by alpha-tocopherol and butylated hydroxytoluene, particularly when present in combination. Key structural features for the catalytic pro-oxidant properties of phenolic antioxidants included two substituents vicinal to the phenolic hydroxyl group.
辅酶 Q10(Q10)在循环系统中主要以其还原形式(泛醇-10;UL10)存在,但在体外迅速氧化为泛醌-10(UN10)。因此,作为氧化还原状态和疾病风险标志物的天然 UL10:UN10 比值难以测量。我们建立了一种反相-(U)HPLC 方法,并用库仑检测来测量天然循环 UL10 和 UN10 浓度,方法是在血浆制备后立即添加泛醇/泛醌混合物作为内标。这允许调整不可避免的人为 UL10 氧化以及分析物在样品储存、处理和分析过程中的总损失(或增益),因为内标与 Q10 的化学行为完全一致。该技术应用于血液(n=13),显示 Q10 水平为 680-3300 nM,平均 UL10:UN10 比值为 95:5,与总 Q10 呈负相关(r=-0.69;p=0.004)。UL10 氧化为 UN10 是等摩尔的,被 O(2) 增加,并被较低的温度或各种脱气方法降低。尽管 UL10 在血液中或在 22 摄氏度的有机溶剂中是稳定的,但它的氧化被α-生育酚和丁基化羟基甲苯剂量依赖性地催化,特别是当它们同时存在时。酚类抗氧化剂的催化促氧化剂特性的关键结构特征包括酚羟基邻位的两个取代基。